HRP20100194T8 - Peri condensed tricyclic compounds useful as antibacterial agents - Google Patents

Peri condensed tricyclic compounds useful as antibacterial agents

Info

Publication number: HRP20100194T8
Authority: HR; Croatia
Prior art keywords: alkyl; cr4r8; aromatic ring; hydroxy; hydrogen
Prior art date: 2005-10-21

Application number

HR20100194T

Other languages

English (en)

Croatian (hr)

Inventor

Cailleau Nathalie

Thomas Davies David

Michael Esken Joel

Joseph Hennessy Alan

Kumar Kusalakumari Sukumar Senthil

Edward Markwell Roger

James Miles Timothy

David Pearson Neil

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-21

Filing date

2010-04-07

Publication date

2010-06-30

2010-04-07 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

2010-05-31 Publication of HRP20100194T1 publication Critical patent/HRP20100194T1/hr

2010-06-30 Publication of HRP20100194T8 publication Critical patent/HRP20100194T8/xx

Links

150000001875 compounds Chemical class 0.000 title abstract 2
239000003242 anti bacterial agent Substances 0.000 title 1
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 8
125000006574 non-aromatic ring group Chemical group 0.000 abstract 7
229910052739 hydrogen Inorganic materials 0.000 abstract 6
239000001257 hydrogen Substances 0.000 abstract 6
125000003118 aryl group Chemical group 0.000 abstract 5
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
101000585507 Solanum tuberosum Cytochrome b-c1 complex subunit 7 Proteins 0.000 abstract 4
229910052736 halogen Inorganic materials 0.000 abstract 4
150000002367 halogens Chemical group 0.000 abstract 4
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
101150020251 NR13 gene Proteins 0.000 abstract 3
125000004414 alkyl thio group Chemical group 0.000 abstract 3
125000003277 amino group Chemical group 0.000 abstract 3
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 3
229910052760 oxygen Inorganic materials 0.000 abstract 3
229910052717 sulfur Inorganic materials 0.000 abstract 3
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
125000004448 alkyl carbonyl group Chemical group 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
125000004429 atom Chemical group 0.000 abstract 2
229910052799 carbon Inorganic materials 0.000 abstract 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
125000004093 cyano group Chemical group *C#N 0.000 abstract 2
125000005647 linker group Chemical group 0.000 abstract 2
229910052757 nitrogen Inorganic materials 0.000 abstract 2
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 1
125000006656 (C2-C4) alkenyl group Chemical group 0.000 abstract 1
125000002527 bicyclic carbocyclic group Chemical group 0.000 abstract 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
125000005842 heteroatom Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

HR20100194T 2005-10-21 2010-04-07 Peri condensed tricyclic compounds useful as antibacterial agents HRP20100194T8 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US72897505P	2005-10-21	2005-10-21
US82659006P	2006-09-22	2006-09-22
PCT/US2006/060023 WO2007081597A2 (en)	2005-10-21	2006-10-17	Peri condensed tricyclic compounds useful as antibacterial agents

Publications (2)

Publication Number	Publication Date
HRP20100194T1 HRP20100194T1 (hr)	2010-05-31
HRP20100194T8 true HRP20100194T8 (en)	2010-06-30

Family

ID=38256822

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20100194T HRP20100194T8 (en)	2005-10-21	2010-04-07	Peri condensed tricyclic compounds useful as antibacterial agents

Country Status (27)

Country	Link
US (2)	US20080280892A1 (de)
EP (1)	EP1954697B1 (de)
JP (1)	JP2009512695A (de)
KR (1)	KR20080064173A (de)
AR (1)	AR057981A1 (de)
AT (1)	ATE458737T1 (de)
AU (1)	AU2006335042A1 (de)
BR (1)	BRPI0617467A2 (de)
CA (1)	CA2626641A1 (de)
CR (1)	CR9930A (de)
CY (1)	CY1110137T1 (de)
DE (1)	DE602006012535D1 (de)
DK (1)	DK1954697T3 (de)
EA (1)	EA200801128A1 (de)
ES (1)	ES2340531T3 (de)
HK (1)	HK1118546A1 (de)
HR (1)	HRP20100194T8 (de)
IL (1)	IL190803A0 (de)
MA (1)	MA29873B1 (de)
NO (1)	NO20082191L (de)
NZ (1)	NZ567315A (de)
PE (1)	PE20070793A1 (de)
PL (1)	PL1954697T3 (de)
PT (1)	PT1954697E (de)
SI (1)	SI1954697T1 (de)
TW (1)	TW200736263A (de)
WO (1)	WO2007081597A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2626641A1 (en) *	2005-10-21	2007-07-19	Glaxo Group Limited	Compounds
US20070185153A1 (en)	2005-12-22	2007-08-09	Nathalie Cailleau	Compounds
ATE481406T1 (de)	2006-04-06	2010-10-15	Glaxo Group Ltd	Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0608263D0 (en)	2006-04-26	2006-06-07	Glaxo Group Ltd	Compounds
GB0613208D0 (en) *	2006-07-03	2006-08-09	Glaxo Group Ltd	Compounds
GB0705672D0 (en) *	2007-03-23	2007-05-02	Glaxo Group Ltd	Compounds
CL2008001002A1 (es)	2007-04-11	2008-10-17	Actelion Pharmaceuticals Ltd	Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
DE602008002912D1 (de) *	2007-04-20	2010-11-18	Glaxo Group Ltd	Tricyclische stickstoffhaltige verbindungen als antibakterielle wirkstoffe
GB0707706D0 (en) *	2007-04-20	2007-05-30	Glaxo Group Ltd	Compounds
EP2005995A1 (de) *	2007-06-22	2008-12-24	Glaxo Group Limited	Heterocyclische Verbindungen für die Behandlung von Tuberkulose
EP2080761A1 (de)	2008-01-18	2009-07-22	Glaxo Group Limited	Verbindungen
US8349828B2 (en)	2008-02-20	2013-01-08	Actelion Pharmaceuticals Ltd.	Azatricyclic antibiotic compounds
CA2720672A1 (en)	2008-04-15	2009-10-22	Actelion Pharmaceuticals Ltd	Tricyclic antibiotics
CN102105467A (zh)	2008-08-04	2011-06-22	埃科特莱茵药品有限公司	三环烷氨基甲基噁唑烷酮衍生物
RU2530884C2 (ru) *	2008-10-07	2014-10-20	Актелион Фармасьютиклз Лтд	Трициклические оксазолидиноновые антибиотические соединения
JP2012505866A (ja) *	2008-10-17	2012-03-08	グラクソグループリミテッド	抗菌剤として使用される三環式窒素化合物
NZ593891A (en)	2008-12-12	2013-05-31	Actelion Pharmaceuticals Ltd	5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
WO2010081874A1 (en)	2009-01-15	2010-07-22	Glaxo Group Limited	Naphthyridin-2 (1 h)-one compounds useful as antibacterials
TW201313726A (zh)	2011-09-16	2013-04-01	Actelion Pharmaceuticals Ltd	製造合成之中間體之方法
US9029368B2 (en)	2011-11-30	2015-05-12	Actelion Pharmaceuticals Ltd.	3,7-disubstituted octahydro-2H-pyrido[4,3-E][1,3]oxazin-2-one antibiotics
SG11201700566SA (en)	2014-08-22	2017-03-30	Glaxosmithkline Ip Dev Ltd	Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
WO2018159609A1 (ja)	2017-02-28	2018-09-07	三井化学アグロ株式会社	植物病害防除組成物およびそれを施用する植物病害の防除方法
WO2018207023A2 (en) *	2017-05-10	2018-11-15	Albajuna Therapeutics, S.L.	Fc-fusion protein derivatives with high dual hiv antiviral and immunomodulatory activity
JP2023506147A (ja)	2019-12-02	2023-02-15	ストーム・セラピューティクス・リミテッド	Ｍｅｔｔｌ３阻害剤としてのポリヘテロ環式化合物
AU2020397059A1 (en)	2019-12-06	2022-07-21	Vertex Pharmaceuticals Incorporated	Substituted tetrahydrofurans as modulators of sodium channels

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3323868A (en) *	1961-12-14	1967-06-06	Laporte Chemical	Manufacture of hydrogen peroxide
BE634031A (de) *	1962-06-23
GB1394373A (en) *	1972-05-17	1975-05-14	Pfizer Ltd	Control of plant diseases
US4066706A (en) *	1975-04-21	1978-01-03	Halcon International, Inc.	Preparation of ethylbenzene hydroperoxide
DE2805915C3 (de) *	1978-02-13	1981-11-05	Dynamit Nobel Ag, 5210 Troisdorf	Reaktor zur Oxidation von Gemischen aus p-Xylol und p-Toluylsäuremethylester mit sauerstoffhaltigen Gasen in flüssiger Phase
DE2914218C2 (de) *	1978-04-12	1985-10-24	Otsuka Pharmaceutical Co. Ltd., Tokio/Tokyo	N-Acylderivate des Ampicillins und Amoxicillins, Verfahren zu deren Herstellung und pharmazeutische Zubereitungen, welche die Verbindungen enthalten
US4416884A (en) *	1978-04-12	1983-11-22	Otsuka Pharmaceutical Co., Ltd.	Piperazinylbenzoheterocyclic compounds
NO156828C (no) *	1980-11-10	1987-12-02	Otsuka Pharma Co Ltd	Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
US4595755A (en) *	1982-03-25	1986-06-17	Ciba-Geigy Corporation	5-halo-1,2,3-(1,2-dihydropyrrolo)-4-quinolones
ATE21514T1 (de) *	1982-03-25	1986-09-15	Ciba Geigy Ag	Verfahren zur herstellung von 1,2,5,6-tetrahydro4h-pyrrolo(3,2,1-ij)-chinolin-4-on und neue 5ch820325
US4443447A (en) *	1982-10-25	1984-04-17	Riker Laboratories, Inc.	Phenyl-substituted tricyclic antibacterial agents
US4603199A (en) *	1982-10-25	1986-07-29	Riker Laboratories, Inc.	Phenyl-substituted tricyclic antibacterial agent intermediates
US6121285A (en) *	1995-11-22	2000-09-19	Daiichi Pharmaceutical Co., Ltd.	Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted aminocycloalkylpyrrolidine derivatives
GB9622386D0 (en) *	1996-10-28	1997-01-08	Sandoz Ltd	Organic compounds
JPH11222407A (ja) *	1997-11-14	1999-08-17	Sankyo Co Ltd	新規殺菌剤
US6289745B1 (en) *	1999-05-04	2001-09-18	James Bowers	High temperature insertion type flow element and mounting extension
US6689765B2 (en) *	1999-05-04	2004-02-10	Schering Corporation	Piperazine derivatives useful as CCR5 antagonists
US7825121B2 (en) *	1999-05-04	2010-11-02	Schering Corporation	Piperazine derivatives useful as CCR5 antagonists
US6391865B1 (en) *	1999-05-04	2002-05-21	Schering Corporation	Piperazine derivatives useful as CCR5 antagonists
GB0101577D0 (en) *	2001-01-22	2001-03-07	Smithkline Beecham Plc	Compounds
AR032920A1 (es) *	2001-03-01	2003-12-03	Smithkline Beecham Corp	Compuestos inhibidores de las peptido-deformilasas y medios para tratar infecciones bacterianas utilizando dichos inhibidores
GB0112836D0 (en) *	2001-05-25	2001-07-18	Smithkline Beecham Plc	Medicaments
EP1470131A2 (de) *	2002-01-29	2004-10-27	Glaxo Group Limited	"aminopiperidinverbindugen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen "
TW200409637A (en) *	2002-06-26	2004-06-16	Glaxo Group Ltd	Compounds
US7196090B2 (en) *	2002-07-25	2007-03-27	Warner-Lambert Company	Kinase inhibitors
TW200427688A (en)	2002-12-18	2004-12-16	Glaxo Group Ltd	Antibacterial agents
RU2350615C2 (ru) *	2003-09-22	2009-03-27	Янссен Фармацевтика, Н.В.	7-аминоалкилиденилгетероциклические хинолоны и нафтиридоны
WO2006002047A2 (en) *	2004-06-15	2006-01-05	Glaxo Group Limited	Antibacterial agents
EP1773831A1 (de) *	2004-07-08	2007-04-18	Glaxo Group Limited	Antibakterielle mittel
US7732612B2 (en) *	2004-09-09	2010-06-08	Janssen Pharmaceutica, N.V.	7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
MY150958A (en) *	2005-06-16	2014-03-31	Astrazeneca Ab	Compounds for the treatment of multi-drug resistant bacterial infections
US8329694B2 (en) *	2005-06-24	2012-12-11	Toyama Chemical Co., Ltd.	Quinoxalinones as antibacterial composition
GB0521563D0 (en) *	2005-10-21	2005-11-30	Glaxo Group Ltd	Novel compounds
CA2626641A1 (en) *	2005-10-21	2007-07-19	Glaxo Group Limited	Compounds
DE102005050892A1 (de) *	2005-10-21	2007-04-26	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
US20070185153A1 (en) *	2005-12-22	2007-08-09	Nathalie Cailleau	Compounds
ATE481406T1 (de) *	2006-04-06	2010-10-15	Glaxo Group Ltd	Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0608263D0 (en) *	2006-04-26	2006-06-07	Glaxo Group Ltd	Compounds
NZ573032A (en) *	2006-05-26	2010-12-24	Taisho Pharmaceutical Co Ltd	Antimicrobial heretocyclic compound and intermediates for its production
GB0613208D0 (en) *	2006-07-03	2006-08-09	Glaxo Group Ltd	Compounds
EP1992628A1 (de) *	2007-05-18	2008-11-19	Glaxo Group Limited	Derivate und Analoge von N-Ethylquinolonen und N-Ethylazaquinolonen
GB0705672D0 (en) *	2007-03-23	2007-05-02	Glaxo Group Ltd	Compounds
EP1980251A1 (de) *	2007-04-13	2008-10-15	Glaxo Group Limited	Pyrrolo[3,2,1-ij]quinolin-4-on Derivate zur Behandlung der Tuberkulose
GB0707708D0 (en) *	2007-04-20	2007-05-30	Glaxo Group Ltd	Compounds
DE602008002912D1 (de) *	2007-04-20	2010-11-18	Glaxo Group Ltd	Tricyclische stickstoffhaltige verbindungen als antibakterielle wirkstoffe
GB0707706D0 (en) *	2007-04-20	2007-05-30	Glaxo Group Ltd	Compounds

2006
- 2006-10-17 CA CA002626641A patent/CA2626641A1/en not_active Abandoned
- 2006-10-17 PT PT06849235T patent/PT1954697E/pt unknown
- 2006-10-17 ES ES06849235T patent/ES2340531T3/es active Active
- 2006-10-17 EP EP06849235A patent/EP1954697B1/de active Active
- 2006-10-17 US US12/090,947 patent/US20080280892A1/en not_active Abandoned
- 2006-10-17 US US11/550,005 patent/US20080221110A1/en not_active Abandoned
- 2006-10-17 PL PL06849235T patent/PL1954697T3/pl unknown
- 2006-10-17 WO PCT/US2006/060023 patent/WO2007081597A2/en active Application Filing
- 2006-10-17 SI SI200630624T patent/SI1954697T1/sl unknown
- 2006-10-17 BR BRPI0617467-1A patent/BRPI0617467A2/pt not_active IP Right Cessation
- 2006-10-17 JP JP2008536625A patent/JP2009512695A/ja active Pending
- 2006-10-17 NZ NZ567315A patent/NZ567315A/en unknown
- 2006-10-17 AU AU2006335042A patent/AU2006335042A1/en not_active Abandoned
- 2006-10-17 AT AT06849235T patent/ATE458737T1/de active
- 2006-10-17 KR KR1020087012082A patent/KR20080064173A/ko not_active Application Discontinuation
- 2006-10-17 EA EA200801128A patent/EA200801128A1/xx unknown
- 2006-10-17 DE DE602006012535T patent/DE602006012535D1/de active Active
- 2006-10-17 DK DK06849235.4T patent/DK1954697T3/da active
- 2006-10-19 AR ARP060104571A patent/AR057981A1/es not_active Application Discontinuation
- 2006-10-19 TW TW095138495A patent/TW200736263A/zh unknown
- 2006-10-19 PE PE2006001266A patent/PE20070793A1/es not_active Application Discontinuation
2008
- 2008-04-10 IL IL190803A patent/IL190803A0/en unknown
- 2008-04-15 MA MA30851A patent/MA29873B1/fr unknown
- 2008-04-25 CR CR9930A patent/CR9930A/es not_active Application Discontinuation
- 2008-05-13 NO NO20082191A patent/NO20082191L/no not_active Application Discontinuation
- 2008-09-10 HK HK08110046.5A patent/HK1118546A1/xx not_active IP Right Cessation
2010
- 2010-04-07 HR HR20100194T patent/HRP20100194T8/xx unknown
- 2010-05-10 CY CY20101100405T patent/CY1110137T1/el unknown

Also Published As

Publication number	Publication date
AR057981A1 (es)	2008-01-09
DE602006012535D1 (de)	2010-04-08
NZ567315A (en)	2011-01-28
AU2006335042A1 (en)	2007-07-19
CY1110137T1 (el)	2015-01-14
US20080280892A1 (en)	2008-11-13
EP1954697B1 (de)	2010-02-24
WO2007081597A3 (en)	2008-06-12
KR20080064173A (ko)	2008-07-08
WO2007081597A2 (en)	2007-07-19
DK1954697T3 (da)	2010-06-14
SI1954697T1 (sl)	2010-05-31
CA2626641A1 (en)	2007-07-19
EA200801128A1 (ru)	2008-10-30
PT1954697E (pt)	2010-05-17
IL190803A0 (en)	2008-12-29
TW200736263A (en)	2007-10-01
NO20082191L (no)	2008-07-16
ATE458737T1 (de)	2010-03-15
PL1954697T3 (pl)	2010-07-30
EP1954697A2 (de)	2008-08-13
HRP20100194T1 (hr)	2010-05-31
JP2009512695A (ja)	2009-03-26
MA29873B1 (fr)	2008-10-03
PE20070793A1 (es)	2007-08-23
HK1118546A1 (en)	2009-02-13
CR9930A (es)	2008-07-29
US20080221110A1 (en)	2008-09-11
ES2340531T3 (es)	2010-06-04
BRPI0617467A2 (pt)	2011-07-26

Publication	Publication Date	Title
HRP20100194T8 (en)	2010-06-30	Peri condensed tricyclic compounds useful as antibacterial agents
AR066111A1 (es)	2009-07-22	Compuesto triciclico de imidazol, su uso para preparar un medicamento, composicion farmaceutica que lo comprende y compuestos intermediarios en la sintesis de dicho compuesto
AR058587A1 (es)	2008-02-13	Compuestos de pirrolo-1,5-naftiridinona,su uso como agentes antibacterianos, composiciones farmaceuticas que los contienen y compuestos intermediarios para preparar dichos compuestos
ECSP066967A (es)	2007-01-26	Derivados de tetrahidroquinolina y un procedimiento para preparar los mismos
AR061918A1 (es)	2008-10-01	Compuesto biciclico que contiene nitrogeno, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende
AR060287A1 (es)	2008-06-04	Compuesto de 5,6 dihidro-3h-pirrolo[1,2,3-de]quinoxalini-3-ona, su uso para preparar un medicamento, composicion farmaceutica que lo comprende y compuesto intermediario util para su preparacion
PE20090276A1 (es)	2009-04-21	Compuestos derivados de imidazoquinolina como moduladores de tlr7
PE20091573A1 (es)	2009-11-12	Derivados heterociclicos de urea como inhibidores de adn girasa y/o topoisomerasa
AR047902A1 (es)	2006-03-01	Compuestos como inhibidores de ns3 serina proteasa del virus de hepatitis c
PE20060770A1 (es)	2006-10-03	Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina como antagonistas de los receptores cannabinoides cb1
AR071385A1 (es)	2010-06-16	Compuestos de 2-imino-3-metil pirrolopirimidinona sustituida con tiofenilo,composiciones farmaceuticas que los contienen,y uso de los mismos para el tratamiento de patologias asociadas con la proteina beta amiloide,tales como alzheimer y otros formas de demencia.
NO20052976L (no)	2005-08-18	Fosfodiesterase-4-inhibitorer.
AR043938A1 (es)	2005-08-17	Compuesto heterociclico derivado de quinolina o naftiridina, composicion farmaceutica que lo comprende y su uso para preparar esta ultima
AR047537A1 (es)	2006-01-25	Piridazinonaureas como antagonistas de integrinas
AR057380A1 (es)	2007-11-28	Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
AR049696A1 (es)	2006-08-30	Derivados de indol
AR047538A1 (es)	2006-01-25	Piridazinonas como antagonistas de las integrinas alfa4
PE20060531A1 (es)	2006-06-28	Derivados de piridazin-3-(2h)-ona como inhibidores de la fosfodiesterasa 4
BRPI0413233A (pt)	2006-10-03	novos compostos
PE20061106A1 (es)	2006-10-13	Derivados de 2-(4-oxo-4h-quinazolin-3-il)acetamida
PE20070321A1 (es)	2007-04-16	Compuestos heterociclicos como inhibidores de proteasas
AR055592A1 (es)	2007-08-29	Derivados de 2-amino-5-cicloalquil-hidantoina como moduladores y/o inhibidores de la beta-secretasa(bace)
PE20060599A1 (es)	2006-08-22	DERIVADOS PIRAZOLO-[3,4-d]-PIRIMIDINA COMO INHIBIDORES DE LA ACTIVIDAD DEL RECEPTOR CANNABINOIDE 1
HRP20090264T1 (en)	2009-06-30	Phenyl-piperazin methanone derivatives
AR049276A1 (es)	2006-07-12	Compuestos carboxamidos opiodes y composiciones farmaceuticas que los contienen